Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of implants are disclosed where the implants can have an elastic main body that is biased towards an at-rest configuration where the body forms multiple expander sections coupled together by interconnect portions. The expander sections can have numerous different shapes and configurations.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Methods are provided for the delivery of an implant into a body lumen of a patient. The method includes the steps of advancing a delivery device that includes a first tubular member housing an implant, a distal control member slidable within the first tubular member and releasably coupled with a distal portion of the implant, and an elongate grasper member slidable within the first tubular member and releasably coupled with a proximal portion of the implant. The method includes causing relative motion between the elongate grasper member and the first tubular member to expose at least a portion of the implant within the first tubular member, and then releasing the distal portion of the implant from the distal control member and the proximal portion of the implant from the elongate grasper member.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Benign prosthetic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. Treatment options for BPH include medication, surgery (e.g., removal of enlarged prostate tissue), and minimally invasive procedures (e.g., needle ablation, electrovaporization, thermotherapy, and stent insertion). Minimally invasive procedure is typically the preferred choice if medication is ineffective. Accordingly, disclosed herein are system and method for treating BPH using improved implant and delivery device. Certain embodiments of the delivery device can include: a camming barrel having a first groove at the distal end of the camming barrel; a sheath, located within a lumen of the camming barrel, for storing the implantable device; and a first cam follower coupled to the sheath.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Systems, devices, and methods are provided for retrieval of an implant from the prostatic urethra. Embodiments of retrieval systems can include a device for insertion into the patient and a proximal control device for use in grasping a portion of the implant and withdrawing the implant into a lumen of the retrieval system.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: A packet switch includes an ingress port; queue admission control circuitry connected to the ingress port; one or more egress queues configured to manage packet buffers; and an egress port connected to the packet buffers, wherein the packet buffers are managed such that already queued lower priority packets are discarded from the packet buffers when it is required to drop higher priority packets that should otherwise be accepted in the packet buffers. The queue admission control circuitry can be configured to determine if a packet should be dropped or not, and the queue admission control circuitry communicates to buffer reallocation circuitry that is configured to discard one or more lower priority packets to support enqueuing the higher priority packet.

Abstract: Benign prosthetic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. Treatment options for BPH include medication, surgery (e.g., removal of enlarged prostate tissue), and minimally invasive procedures (e.g., needle ablation, electrovaporization, thermotherapy, and stent insertion). Minimally invasive procedure is typically the preferred choice if medication is ineffective. Accordingly, disclosed herein are system and method for treating BPH using improved implant and delivery device. Certain embodiments of the delivery device can include: a camming barrel having a first groove at the distal end of the camming barrel; a sheath, located within a lumen of the camming barrel, for storing the implantable device; and a first cam follower coupled to the sheath.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Abstract: A packet queueing system includes an ingress port configured to receive packets; queueing logic communicatively coupled to one or more egress queues for transmission via an egress port, wherein the queueing logic is configured to maintain an Acceptable Burst Size (ABS) token bucket which is set to enable absorption of microbursts, and implement a congestion avoidance algorithm to one of randomly drop packets and queue packets, wherein the congestion avoidance algorithm only performs the randomly drop packets responsive to the ABS token bucket being empty.

Abstract: Benign prosthetic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. Treatment options for BPH include medication, surgery (e.g., removal of enlarged prostate tissue), and minimally invasive procedures (e.g., needle ablation, electrovaporization, thermotherapy, and stent insertion). Minimally invasive procedure is typically the preferred choice if medication is ineffective. Accordingly, disclosed herein are system and method for treating BPH using improved implant and delivery device. Certain embodiments of the delivery device can include: a camming barrel having a first groove at the distal end of the camming barrel; a sheath, located within a lumen of the camming barrel, for storing the implantable device; and a first cam follower coupled to the sheath.

Abstract: A packet switch includes an ingress port; queue admission control circuitry connected to the ingress port; one or more egress queues configured to manage packet buffers; and an egress port connected to the packet buffers, wherein the packet buffers are managed such that already queued lower priority packets are discarded from the packet buffers when it is required to drop higher priority packets that should otherwise be accepted in the packet buffers. The queue admission control circuitry can be configured to determine if a packet should be dropped or not, and the queue admission control circuitry communicates to buffer reallocation circuitry that is configured to discard one or more lower priority packets to support enqueuing the higher priority packet.